首页 - 股票 - 研报 - 趋势策略 - 正文

China Consumer Staples:Look beyond near-term Dairy woes;Mengniu profit warning

关注证券之星官方微博:

Mengniu FY16 profit warning a surprise

On Dec 15, Mengniu issued a profit warning stating that in 2016 it willshow a substantial loss due to: (1) Infant milk formula (IMF) sub Yashili'sgoodwill impairment; and (2) disposal loss on excessive sprayed milkpowder inventory (mgmt. estimate Rmb600mn). While the impairment hadbeen expected by the market, the magnitude was a surprise to us. Weestimate Mengniu will record Rmb3.0-3.5bn impairment losses for 2016(this compares to its 2015 net profit of Rmb2.3bn). We revise our 2016reported EPS to Rmb(0.23) from Rmb0.50 and recurring EPS by -8% fromRmb0.59 to Rmb0.54 due to higher COGS from #2 above, and view #1 as aone-off. Our 12-month target price has not changed under our 2018EEV/GCI vs. CROCI/WACC framework and remains HK$17.8; retain Buy.

Mengniu new CEO’s initiatives: focus on improving efficiency

New CEO Mr. Lu Minfang has also set out his reform plan. Key initiatives:1) streamline headquarters and offer wide decision-making autonomy toeach business unit and 2) centralize procurement. For #1, each businessunit will now have independent P&L metrics internally, enabling businessdecision making (e.g. large scale marketing campaign) without seekingapproval. For #2, the company plans to procure all its milk under the sameplatform and increase the use of imported milk powder for low-end UHTmilk. We think the initiatives will allow Mengniu to more quickly adapt tomarket conditions and improve operational efficiency. 2017 Guidance:Mengniu's priority is profit growth. It aims to maintain higher than industrysales growth while also focusing on improving profit margins. We seesome gross margin upside from using lower-cost milk powder inventoryand as industry prices fall in 2017. We have already built some marginexpansion into GPM.

IMF competition still intense, CMD raw milk price upside limited

We think Yashili's unfavorable result plus weak results from peers (Yili [Buy],Biostime [Neutral], Beingmate [NC]) indicate the IMF market still facesintense competition in next 6 months. Mengniu’s new procurement policyimplies more stable volume for China Modern Dairy (Neutral) (Mengniubuys 70% of CMD’s milk), but we see limited upside risk for raw milk pricesas Mengniu shifts toward market pricing and a focus on gross margins.





微信
扫描二维码
关注
证券之星微信
APP下载
下载证券之星
郑重声明:以上内容与证券之星立场无关。证券之星发布此内容的目的在于传播更多信息,证券之星对其观点、判断保持中立,不保证该内容(包括但不限于文字、数据及图表)全部或者部分内容的准确性、真实性、完整性、有效性、及时性、原创性等。相关内容不对各位读者构成任何投资建议,据此操作,风险自担。股市有风险,投资需谨慎。如对该内容存在异议,或发现违法及不良信息,请发送邮件至jubao@stockstar.com,我们将安排核实处理。如该文标记为算法生成,算法公示请见 网信算备310104345710301240019号。
网站导航 | 公司简介 | 法律声明 | 诚聘英才 | 征稿启事 | 联系我们 | 广告服务 | 举报专区
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-